One Drop obtains CE Mark for AI-based blood glucose predictions

27 May 2021

CE Mark

One Drop’s Blood Glucose Prediction Analysis Engine, which can estimate glucose levels of diabetic patients, gets CE Mark.

One Drop has received CE Mark for the Blood Glucose Prediction Analysis Engine to precisely estimate glucose levels for people with prediabetes, as well as type 2 and gestational diabetes.

The company noted that its tool can predict glucose levels up to eight hours in advance.

The latest approval is based on the accuracy and self-reported use of the company’s eight-hour glucose forecasts, One Drop added.

Compared with other digital health solutions, which use machine learning for backend infrastructure, One Drop utilises artificial intelligence (AI) to provide quick insights to users.

The One Drop app users get glucose forecasts and behavioural predictions upon the availability of the latest data on food, physical activity or glucose.

Digital membership users can also utilise the app to get personalised coaching, interactive educational content and health data tracking tools.

One Drop CEO and founder Jeff Dachis said: “Receiving the CE Mark reflects One Drop’s commitment to quality, safety, and compliance for the benefit of our global community.

“This recognition helps us on our mission to transform health, change lives, and create opportunities. By empowering people living with chronic conditions to finely tune their decisions, One Drop sets them on the path to better health outcomes, peak performance, and a more fulfilling life.”

The app obtains glucose, weight, blood pressure, food, medicines, and physical activity via manual input, connected medical devices such as the One Drop meter and direct combinations with HealthKit, GoogleFit, Dexcom, Fitbit, Apple Watch and Companion Medical.

One Drop noted that 94% of app users who gave survey feedback said that the glucose forecasts and insights were beneficial.

By connecting daily behaviours with outcomes, glucose predictions and insights assist healthy decisions and provide ongoing assistance to supplement the support from the healthcare provider.

As One Drop’s algorithms depend on its data wealth instead of continuous glucose testing, the AI-driven feature can considerably decrease the use of fingerstick glucose checking.

Would you, as a professional in the Medical Devices industry, also like to contribute to innovative blood glucose technology for an organisation? Click HERE!

Published on


Sign up

    Fill in your contact details to sign up for our newsletter.